These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 35799474)

  • 1. Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in Norway.
    Stålcrantz J; Kristoffersen AB; Bøås H; Veneti L; Seppälä E; Aasand N; Hungnes O; Kvåle R; Bragstad K; Buanes EA; Whittaker R
    Scand J Public Health; 2022 Aug; 50(6):676-682. PubMed ID: 35799474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Biochemical Characteristics of COVID-19 Patients During the Delta-Omicron Wave with Risk Assessment of Adverse Outcomes.
    Iqbal S; Khan S; Qureshi MA; Sayeed MA; Khan BA; Zaheer S; Faruqui H; Rajput AW
    J Coll Physicians Surg Pak; 2023 Mar; 33(3):297-302. PubMed ID: 36945160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant.
    Butt AA; Dargham SR; Loka S; Shaik RM; Chemaitelly H; Tang P; Hasan MR; Coyle PV; Yassine HM; Al-Khatib HA; Smatti MK; Kaleeckal AH; Latif AN; Zaqout A; Almaslamani MA; Al Khal A; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
    Clin Infect Dis; 2022 Aug; 75(1):e361-e367. PubMed ID: 35404391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Relative to Delta in British Columbia, Canada: A Retrospective Analysis of Whole-Genome Sequenced Cases.
    Harrigan SP; Wilton J; Chong M; Abdia Y; Velasquez Garcia H; Rose C; Taylor M; Mishra S; Sander B; Hoang L; Tyson J; Krajden M; Prystajecky N; Janjua NZ; Sbihi H
    Clin Infect Dis; 2023 Feb; 76(3):e18-e25. PubMed ID: 36041009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022.
    Veneti L; Bøås H; Bråthen Kristoffersen A; Stålcrantz J; Bragstad K; Hungnes O; Storm ML; Aasand N; Rø G; Starrfelt J; Seppälä E; Kvåle R; Vold L; Nygård K; Buanes EA; Whittaker R
    Euro Surveill; 2022 Jan; 27(4):. PubMed ID: 35086614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical characteristics and outcomes of critically ill adults with SARS-CoV-2 infection during Delta and Omicron variant predominance periods: a single-hospital retrospective cohort study.
    Sankar K; Modi N; Polyak A; Directo MP; Johnson LR; Kho N; Isonaka SK; Pedraza I; Chen P; Modes ME
    BMJ Open Respir Res; 2023 Feb; 10(1):. PubMed ID: 36805880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United Kingdom.
    Hyams C; Challen R; Marlow R; Nguyen J; Begier E; Southern J; King J; Morley A; Kinney J; Clout M; Oliver J; Gray S; Ellsbury G; Maskell N; Jodar L; Gessner B; McLaughlin J; Danon L; Finn A;
    Lancet Reg Health Eur; 2023 Feb; 25():100556. PubMed ID: 36530491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar.
    Butt AA; Dargham SR; Tang P; Chemaitelly H; Hasan MR; Coyle PV; Kaleeckal AH; Latif AN; Loka S; Shaik RM; Zaqout A; Almaslamani MA; Al Khal A; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
    J Glob Health; 2022 Jul; 12():05032. PubMed ID: 35788085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
    Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
    Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019-positive patients.
    Hu FH; Jia YJ; Zhao DY; Fu XL; Zhang WQ; Tang W; Hu SQ; Wu H; Ge MW; Du W; Shen WQ; Zhu B; Chen HL
    Clin Microbiol Infect; 2023 Jul; 29(7):835-844. PubMed ID: 36934872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients.
    Whittaker R; Bråthen Kristofferson A; Valcarcel Salamanca B; Seppälä E; Golestani K; Kvåle R; Watle SV; Buanes EA
    Clin Microbiol Infect; 2022 Jun; 28(6):871-878. PubMed ID: 35219807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical progression, disease severity, and mortality among adults hospitalized with COVID-19 caused by the Omicron and Delta SARS-CoV-2 variants: A population-based, matched cohort study.
    COVID-19 Omicron Delta study group
    PLoS One; 2023; 18(4):e0282806. PubMed ID: 37104488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022.
    Piralla A; Mojoli F; Pellegrinelli L; Ceriotti F; Valzano A; Grasselli G; Gismondo MR; Micheli V; Castelli A; Farina C; Arosio M; Lorini FL; Fanti D; Busni A; Laratta M; Maggi F; Novazzi F; Cabrini L; Callegaro AP; Keim R; Remuzzi G; Cavallero A; Malandrin SMI; Rona R; Giardina F; Ferrari G; Zavaglio F; D'angelo P; Galli C; Bubba L; Binda S; Oggioni M; Uceda Renteria SC; Bono P; Baj A; Ferrante FD; Guarneri D; Tonelli M; Napolitano G; Nava A; Romeo L; Nicolini E; Valaperta R; Varisano L; Mele C; Liguori L; Raggi M; Mongodi S; Pagani M; Severgnini P; Gasberti D; Bonanomi E; Gritti P; Marrazzo F; Giovannini I; Sacchi N; Sagliocco O; Cereda D; Buoro S; Baldanti F; Pariani E
    Respir Med Res; 2023 Jun; 83():100990. PubMed ID: 36871459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective Observational Study of Complete Blood Count (CBC) Parameters and ICU Mortality of COVID-19 Disease in Delta Variant and Omicron Variant in a Community-Based Hospital in New York City.
    Yadav R; Yadav V; Pokhriyal S; Zahid U; Gandhi A
    Cureus; 2023 Feb; 15(2):e34894. PubMed ID: 36925973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study.
    Bouzid D; Visseaux B; Kassasseya C; Daoud A; Fémy F; Hermand C; Truchot J; Beaune S; Javaud N; Peyrony O; Chauvin A; Vaittinada Ayar P; Bourg A; Riou B; Marot S; Bloom B; Cachanado M; Simon T; Freund Y;
    Ann Intern Med; 2022 Jun; 175(6):831-837. PubMed ID: 35286147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland.
    Portmann L; de Kraker MEA; Fröhlich G; Thiabaud A; Roelens M; Schreiber PW; Troillet N; Iten A; Widmer A; Harbarth S; Sommerstein R;
    JAMA Netw Open; 2023 Feb; 6(2):e2255599. PubMed ID: 36790812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmissibility, hospitalization, and intensive care admissions due to omicron compared to delta variants of SARS-CoV-2 in Catalonia: A cohort study and ecological analysis.
    Català M; Coma E; Alonso S; Andrés C; Blanco I; Antón A; Bordoy AE; Cardona PJ; Fina F; Martró E; Medina M; Mora N; Saludes V; Prats C; Prieto-Alhambra D; Alvarez-Lacalle E
    Front Public Health; 2022; 10():961030. PubMed ID: 36033822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.